Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-24T07:24:35.227Z Has data issue: false hasContentIssue false
  • English
  • Français

Bloodstream Infections in Pediatric Oncology Outpatients: A New Healthcare Systems Challenge

Published online by Cambridge University Press:  02 January 2015

Theresa L. Smith ,
Gregg T. Pullen ,
Vonda Crouse ,
Jon Rosenberg  and
William R. Jarvis
Theresa L. Smith*
Affiliation:
Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia
Gregg T. Pullen
Affiliation:
Fresno Children's Hospital, Fresno, California
Vonda Crouse
Affiliation:
Fresno Children's Hospital, Fresno, California
Jon Rosenberg
Affiliation:
California Department of Health Services, Berkeley, California
William R. Jarvis
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Atlanta, Georgia
*
Epidemiology Program Office, New Mexico Department of Health, 1190 St. Francis Dr., N 1307, Santa Fe, NM 87505
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To investigate a perceived increase in central venous catheter (CVC)–associated bloodstream infections (BSIs) among pediatric hematology–oncology outpatients.

Design:

A case–control study.

Setting:

A pediatric hematology–oncology outpatient clinic at Fresno Children's Hospital.

Patients:

Pediatric hematology–oncology clinic outpatients with CVCs at Fresno Children's Hospital between November 1994 and October 1997.

Methods:

A case-patient was defined as any hematology–oncology outpatient with a CVC-associated BSI at Fresno Children's Hospital from November 1996 to October 1997 (study period) without a localizable infection. To identify case-patients, we reviewed Fresno Children's Hospital records for all hematology–oncology clinic patients, those with CVCs and those with CVCs and BSIs. Control-patients were randomly selected hematology–oncology outpatients with a CVC but no BSI during the study period. Case-patient and control-patient demographics, diagnoses, caretakers, catheter types, catheter care, and water exposure were compared.

Results:

Twenty-five case-patients had 42 CVC-associated BSIs during the study period. No significant increase in CVC-associated BSI rates occurred among pediatric hematology–oncology patients. However, there was a statistically significant increase in nonendogenous, gram-negative (eg, Pseudomonas species) BSIs during summer months (May–October) compared with the rest of the year. Case-patients and control-patients differed only in catheter type; case-patients were more likely than control-patients to have a transcutaneous CVC. Summertime recreational water exposures were similar and high in the two groups.

Conclusions:

Hematology–oncology clinic patients with transcutaneous CVCs are at greater risk for CVC-associated BSI, particularly during the summer. Caretakers should be instructed on proper care of CVCs, particularly protection of CVCs during bathing and recreational summer water activities, to reduce the risk of nonendogenous, gram-negative BSIs.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 5 , May 2002 , pp. 239 - 243
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Johnson, P, Decker, MD, Edwards, K, Schaffner, W, Wright, P. Frequency of Broviac catheter infection in pediatric oncology patients. J Infect Dis 1986;154:570–578.CrossRefGoogle ScholarPubMed
2.Banerjee, S, Emori, T, Culver, D, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91:86S–89S.CrossRefGoogle ScholarPubMed
3.Rose, R, Hunting, K, Townsend, T, Wenzel, RP. Morbidity, mortality and economics of hospital-acquired blood stream infections: a controlled study. South Med J 1977;70:1267–1269.Google Scholar
4.Emori, T, Culver, D, Horan, TC, et al. National Nosocomial Infections Surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991;19:19–35.Google Scholar
5.American Medical Association Council on Scientific Affairs. Home care in the 1990s. JAMA 1990;263:1241–1244.Google Scholar
6.Joint Commission on the Accreditation of Healthcare Organizations. Safety management and infection control. In: Joint Commission on the Accreditation of Healthcare Organizations. Standard for the Accreditation of Home Care. Chicago: Joint Commission on the Accreditation of Healthcare Organizations; 1988:22.Google Scholar
7.Rhame, F. Surveillance objectives: descriptive epidemiology. Infect Control Hosp Epidemiol 1987:8:454–458.Google Scholar
8.Kellerman, S, Shay, D, Howard, J, et al. Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr 1996;129:711–717.CrossRefGoogle Scholar
9.Hartman, G, Shochat, S. Management of septic complications associated with Silastic catheters in childhood malignancy. Pediatr Infect Dis J 1987;6:1042–1047.Google Scholar
10.McDonald, L, Banerjee, S, Jarvis, W. Seasonal variation of Acinetobacter infections: 1987-1996. Clin Infect Dis 1999;29:1133–1137.CrossRefGoogle ScholarPubMed
11.Retaillau, H, Hightower, A, Dixon, R, Allen, J. Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern. J Infect Dis 1979;130:371–375.CrossRefGoogle Scholar
12.Siau, H, Yuen, K, Wong, S, Ho, P, Luk, W. The epidemiology of Acinetobacter infections in Hong Kong. J Med Microbiol 1996;44:340–347.Google Scholar
13.Funada, H, Matsuda, T. Aeromonas bacteremia in patients with hematologic diseases. Intern Med 1997;36:171–174.CrossRefGoogle ScholarPubMed